Vivek Sharma

Dr Lal PathLabs Q1 FY25 reported profit above expectations, Share surge 5.67% today

by
Dr Lal PathLabs Q1 FY25 reported profit above expectations

Dr. Lal PathLabs reported strong Q1 FY25 results, beating analyst estimates and driving a 5.67% increase in share price. The company exceeded analyst expectations with a 28% YoY increase in net profit and a 16.4% YoY increase in EBITDA. Dr. Lal PathLabs is benefiting from rising health awareness and increased demand for medical tests, particularly Read more: Dr Lal PathLabs Q1 FY25 reported profit above expectations, Share surge 5.67% today..

Stock Market Today: Share Market rebounded, ending 3-day losing streak

by
Share Market rebounded, ending 3-day losing streak

Stock Market Today: Share Market rebounded on Wednesday, ending a three-day losing streak and joining a global rally as fears of a U.S. recession eased. The NSE Nifty 50 index and the S&P BSE Sensex both gained over 1%, driven by a surge in oil and gas and public sector stocks.   Share Market today Read more: Stock Market Today: Share Market rebounded, ending 3-day losing streak..

Sebi proposes relaxations for investment advisors and research analysts rules

by
Sebi proposes relaxations for investment advisors and research analysts rules

The Securities and Exchange Board of India (SEBI) has proposed significant relaxations to the regulations governing investment advisors (IAs) and research analysts (RAs) in India. By easing the regulatory burden, SEBI aims to encourage more individuals to become registered IAs and RAs, thereby increasing the pool of qualified professionals in the market. The changes aim Read more: Sebi proposes relaxations for investment advisors and research analysts rules..